| Characterization of peptides bound to the class I MHC molecule HLA-A2. 1 by mass spectrometry DF Hunt, RA Henderson, J Shabanowitz, K Sakaguchi, H Michel, N Sevilir, ... Science 255 (5049), 1261-1263, 1992 | 1658 | 1992 |
| Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines AL Cox, J Skipper, Y Chen, RA Henderson, TL Darrow, J Shabanowitz, ... Science 264 (5159), 716-719, 1994 | 1140 | 1994 |
| Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad DF Hunt, H Michel, TA Dickinson, J Shabanowitz, AL Cox, K Sakaguchi, ... Science 256 (5065), 1817-1820, 1992 | 866 | 1992 |
| Protection against persistence of hepatitis C SH Mehta, A Cox, DR Hoover, XH Wang, Q Mao, S Ray, SA Strathdee, ... The Lancet 359 (9316), 1478-1483, 2002 | 575 | 2002 |
| The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection J Grebely, K Page, R Sacks‐Davis, MS van der Loeff, TM Rice, J Bruneau, ... Hepatology 59 (1), 109-120, 2014 | 503 | 2014 |
| Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection WO Osburn, BE Fisher, KA Dowd, G Urban, L Liu, SC Ray, DL Thomas, ... Gastroenterology 138 (1), 315-324, 2010 | 420 | 2010 |
| A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune … DT Le, DG Brockstedt, R Nir-Paz, J Hampl, S Mathur, J Nemunaitis, ... Clinical cancer research 18 (3), 858-868, 2012 | 384 | 2012 |
| Cellular immune selection with hepatitis C virus persistence in humans AL Cox, T Mosbruger, Q Mao, Z Liu, XH Wang, HC Yang, J Sidney, ... The Journal of experimental medicine 201 (11), 1741-1752, 2005 | 382 | 2005 |
| Human immunodeficiency virus-related microbial translocation and progression of hepatitis C A Balagopal, FH Philp, J Astemborski, TM Block, A Mehta, R Long, ... Gastroenterology 135 (1), 226-233, 2008 | 348 | 2008 |
| Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C AL Cox, T Mosbruger, GM Lauer, D Pardoll, DL Thomas, SC Ray Hepatology 42 (1), 104-112, 2005 | 321 | 2005 |
| Prospective evaluation of community-acquired acute-phase hepatitis C virus infection AL Cox, DM Netski, T Mosbruger, SG Sherman, S Strathdee, D Ompad, ... Clinical infectious diseases 40 (7), 951-958, 2005 | 314 | 2005 |
| Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses WO Osburn, AE Snider, BL Wells, R Latanich, JR Bailey, DL Thomas, ... Hepatology 59 (6), 2140-2151, 2014 | 288 | 2014 |
| Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus KA Dowd, DM Netski, XH Wang, AL Cox, SC Ray Gastroenterology 136 (7), 2377-2386, 2009 | 274 | 2009 |
| Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine J Grebely, M Prins, M Hellard, AL Cox, WO Osburn, G Lauer, K Page, ... The Lancet infectious diseases 12 (5), 408-414, 2012 | 267 | 2012 |
| Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts P Duggal, CL Thio, GL Wojcik, JJ Goedert, A Mangia, R Latanich, AY Kim, ... Annals of internal medicine 158 (4), 235-245, 2013 | 248 | 2013 |
| Approaches, progress, and challenges to hepatitis C vaccine development JR Bailey, E Barnes, AL Cox Gastroenterology 156 (2), 418-430, 2019 | 243 | 2019 |
| Humoral immune response in acute hepatitis C virus infection DM Netski, T Mosbruger, E Depla, G Maertens, SC Ray, RG Hamilton, ... Clinical infectious diseases 41 (5), 667-675, 2005 | 238 | 2005 |
| TGFβ1-mediated SMAD3 enhances PD-1 expression on antigen-specific T cells in cancer BV Park, ZT Freeman, A Ghasemzadeh, MA Chattergoon, ... Cancer discovery 6 (12), 1366-1381, 2016 | 230 | 2016 |
| HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon MA Chattergoon, R Latanich, J Quinn, ME Winter, RW Buckheit 3rd, ... PLoS pathogens 10 (5), e1004082, 2014 | 193 | 2014 |
| Recognition of human melanoma cells by HLA-A2. 1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. CL Slingluff Jr, AL Cox, RA Henderson, DF Hunt, VH Engelhard Journal of immunology (Baltimore, Md.: 1950) 150 (7), 2955-2963, 1993 | 178 | 1993 |
Stuart C. Ray, M.D.Professor of Medicine and Oncology, Johns Hopkins University School of Medicine在 jhmi.edu 的电子邮件经过验证
